TECHNE Corporation is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through its wholly owned subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems), Boston Biochem, Inc. (Boston Biochem), and BiosPacific, Inc. (BiosPacific). The Company operates in two segments: biotechnology and hematology. The Company's biotechnology reporting segment develops, manufactures and sells biotechnology research and diagnostic products world-wide. The Company's hematology reporting segment, which consists of R&D Systems' Hematology Division, develops and manufactures hematology controls and calibrators for sale worldwide.
|Headquarters||614 McKinley Place N.E.|
MINNEAPOLIS, MN, United States 55413-2610
|Chairman of the Board||Robert Baumgartner|
|Chief Executive Officer, Director||Charles Kummeth|
|Independent Vice Chairman of the Board||Roger Lucas|
|Chief Financial Officer, Vice President - Finance||Gregory Melsen|
|Vice President - Hematology Operations||Marcel Veronneau|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||36.8M||Book Value||$18.31|
|Annual Dividend Rate||$1.20||Price/Sales (TTM)||7.9|
|Ex-Div Date||5/8/13||P/Cash Flow (TTM)||20.2x|
|Pay Date||8/8/13||Operating Margin||51.61%|
*GAAP = prior to non-GAAP analyst adjusted earnings.